BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 21537538)

  • 1. Impact of prolonged 48-h wireless capsule esophageal pH monitoring on diagnosis of gastroesophageal reflux disease and evaluation of the relationship between symptoms and reflux episodes.
    Domingues GR; Moraes-Filho JP; Domingues AG
    Arq Gastroenterol; 2011; 48(1):24-9. PubMed ID: 21537538
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 24 Versus 48-hour bravo pH monitoring.
    Chander B; Hanley-Williams N; Deng Y; Sheth A
    J Clin Gastroenterol; 2012 Mar; 46(3):197-200. PubMed ID: 21959323
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Day-to-day variability in acid reflux patterns using the BRAVO pH monitoring system.
    Ahlawat SK; Novak DJ; Williams DC; Maher KA; Barton F; Benjamin SB
    J Clin Gastroenterol; 2006 Jan; 40(1):20-4. PubMed ID: 16340628
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparative study of two modes of gastroesophageal reflux measuring: conventional esophageal pH monitoring and wireless pH monitoring.
    Azzam RS; Sallum RA; Brandão JF; Navarro-Rodriguez T; Nasi A
    Arq Gastroenterol; 2012; 49(2):107-12. PubMed ID: 22766996
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Performance, tolerability, and symptoms related to prolonged pH monitoring using the Bravo system in Mexico.
    Remes-Troche JM; Ibarra-Palomino J; Carmona-Sánchez RI; Valdovinos MA
    Am J Gastroenterol; 2005 Nov; 100(11):2382-6. PubMed ID: 16279888
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interference with daily activities and major adverse events during esophageal pH monitoring with bravo wireless capsule versus conventional intranasal catheter: a systematic review of randomized controlled trials.
    Iluyomade A; Olowoyeye A; Fadahunsi O; Thomas L; Libend CN; Ragunathan K; Fenster J; Vignesh S
    Dis Esophagus; 2017 Feb; 30(3):1-9. PubMed ID: 26952638
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical utility and tolerability of JSPH-1 wireless esophageal pH monitoring system.
    Li JN; Liu CL; Tao XH
    BMC Gastroenterol; 2013 Jan; 13():10. PubMed ID: 23317032
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Wireless esophageal pH capsule for patients with gastroesophageal reflux disease: a multicenter clinical study.
    Yang XJ; Gan T; Wang L; Liao Z; Tao XH; Shen W; Zhao XY
    World J Gastroenterol; 2014 Oct; 20(40):14865-74. PubMed ID: 25356046
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Wireless pH capsule--yield in clinical practice.
    Roman S; Mion F; Zerbib F; Benamouzig R; Letard JC; Bruley des Varannes S
    Endoscopy; 2012 Mar; 44(3):270-6. PubMed ID: 22275050
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Endoscopic pH monitoring for patients with suspected or refractory gastroesophageal reflux disease.
    Turner BG; Saltzman JR; Hua L; Maurer R; Feldman N; Carr-Locke DL; Burakoff R; Liu JJ
    Can J Gastroenterol; 2007 Nov; 21(11):737-41. PubMed ID: 18026578
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of measurement of esophageal acid exposure close to the gastroesophageal junction on diagnostic accuracy and event-symptom correlation: a prospective study using wireless dual pH monitoring.
    Bansal A; Wani S; Rastogi A; Rastogi K; Goyal A; Hall S; Singh V; Higbee A; Sharma P
    Am J Gastroenterol; 2009 Dec; 104(12):2918-25. PubMed ID: 19755975
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Radiographic demonstration of a wireless capsule pH monitor in the esophagus.
    Javors BR; Bukman R
    Dysphagia; 2011 Jun; 26(2):193-5. PubMed ID: 20443028
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Catheter-free pH-metry using the Bravo capsule versus standard pH-metry in patients with non-erosive reflux disease (NERD)].
    Mönkemüller K; Neumann H; Fry LC; Kolfenbach S; Malfertheiner P
    Z Gastroenterol; 2009 Apr; 47(4):351-6. PubMed ID: 19358061
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Wireless ambulatory pH studies: manometric or endoscopic guidance?
    Nusrat S; Roy PM; Bielefeldt K
    Dis Esophagus; 2012 Jan; 25(1):26-32. PubMed ID: 21676068
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Oesophageal pH monitoring using the Bravo catheter-free radio capsule.
    Gillies RS; Stratford JM; Booth MI; Dehn TC
    Eur J Gastroenterol Hepatol; 2007 Jan; 19(1):57-63. PubMed ID: 17206078
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Wireless capsules for esophageal pH monitoring: are we placing them correctly?
    Doma S; Paladugu S; Parkman HP; Friedenberg FK
    Digestion; 2010; 82(1):54-9. PubMed ID: 20215751
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Safety and Efficacy of Wireless pH Monitoring in Patients Suspected of Gastroesophageal Reflux Disease: A Systematic Review.
    Kessels SJM; Newton SS; Morona JK; Merlin TL
    J Clin Gastroenterol; 2017 Oct; 51(9):777-788. PubMed ID: 28877081
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Wireless esophageal pH monitoring: new technique means new questions.
    Bhat YM; McGrath KM; Bielefeldt K
    J Clin Gastroenterol; 2006 Feb; 40(2):116-21. PubMed ID: 16394871
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of data obtained from sedated versus unsedated wireless telemetry capsule placement: does sedation affect the results of ambulatory 48-hour pH testing?
    Belafsky PC; Godin DA; Garcia JC; Rahim N
    Laryngoscope; 2005 Jun; 115(6):1109-13. PubMed ID: 15933532
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nonendoscopic transnasal placement of a wireless capsule for esophageal pH monitoring: feasibility, safety, and efficacy of a manometry-guided procedure.
    Marchese M; Spada C; Iacopini F; Familiari P; Shah SG; Tringali A; Costamagna G
    Endoscopy; 2006 Aug; 38(8):813-8. PubMed ID: 17001571
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.